Goodwill and Intangible Assets - Narrative (Details) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Finite-Lived Intangible Assets [Line Items] | |||
Accumulated goodwill impairment losses | $ 8.3 | $ 8.3 | |
Goodwill impairment loss | 0.0 | 0.0 | $ 0.0 |
Aggregate amortization expense | 49.6 | 58.6 | 60.7 |
Impairment of intangible assets | 1.6 | 28.7 | $ 3.3 |
ArraVasc Limited | |||
Finite-Lived Intangible Assets [Line Items] | |||
Impairment of intangible assets | $ 1.6 | 4.8 | |
STD Pharmaceutical Products Limited | |||
Finite-Lived Intangible Assets [Line Items] | |||
Impairment of intangible assets | 8.2 | ||
Laurane Medical S.A.S. | |||
Finite-Lived Intangible Assets [Line Items] | |||
Impairment of intangible assets | 8.0 | ||
Other Acquisitions | |||
Finite-Lived Intangible Assets [Line Items] | |||
Impairment of intangible assets | $ 7.7 |